Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8552037
Tricyclic compound and pharmaceutical use thereof
granted -
US 8541417
Poly (ADP-ribose) polymerase (PARP) inhibitors
granted -
US 8541024
Film-coated scored tablet
granted -
US 8518890
Remedies for sex hormone dependent disease
granted -
US 8513251
Pyridazinone compounds
granted -
US 8501750
Heterocyclic compound and use thereof
granted -
US 8501804
Bicyclic compound
granted -
US 8497274
Heterocyclic compound and use thereof
granted -
US 8492405
Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity
granted -
US 8492378
GSK-3β inhibitor
granted -
US 8492430
Fused cyclic compounds
granted -
US 8486965
Pyrrolo[2,3-b]pyridine derivative and use thereof for treatment of cancer
granted -
US 8486450
Method of producing solid preparation disintegrating in the oral cavity
granted -
US 8481569
Iminopyridine derivatives and use thereof
granted -
US 8470859
Iminopyridine derivative and use thereof
granted -
US 8470837
MAPK/ERK kinase inhibitors
granted -
US 8470816
Nitrogen-containing heterocyclic compound and use thereof
granted -
US 8466282
Heterocyclic compound and use thereof
granted -
US 8461348
Heterocyclic derivative and use thereof
granted -
US 8461163
Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1
granted -
US 8450070
Method for screening of cell-protecting agent
granted -
US 8450323
Substituted derivatives of pyrido[3,2-e][1,4]thiazino[4,3-a]pyrazine and pyrido[3,2-e][1,4]oxazino[4,3-a]pyrazine
granted -
US 8449911
Drug composition having active ingredient adhered at high concentration to spherical core
granted -
US 8445509
Fused heterocyclic derivatives and use thereof
granted